Company Filing History:
Years Active: 2011-2015
Title: Lihong Shen: Innovator in Pharmaceutical Chemistry
Introduction
Lihong Shen is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating depression. With a total of 2 patents to her name, her work is paving the way for new therapeutic options.
Latest Patents
Lihong Shen's latest patents focus on ethanamine compounds and their applications. The first patent, titled "Ethanamine compounds and methods of using the same," is directed towards ethanamine compounds and pharmaceutical compositions that utilize these compounds. This invention outlines methods for treating depression by administering the ethanamine compound. The second patent, which shares a similar title, further emphasizes the importance of these compounds in pharmaceutical applications.
Career Highlights
Lihong Shen is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves extensive research and development in the field of drug discovery, where she applies her expertise in chemistry to create innovative solutions for mental health treatment.
Collaborations
Throughout her career, Lihong has collaborated with notable colleagues, including Michael Balestra and Peter Robert Bernstein. These collaborations have enhanced her research and contributed to the advancement of her projects.
Conclusion
Lihong Shen's work in developing ethanamine compounds represents a significant advancement in the treatment of depression. Her contributions to pharmaceutical chemistry continue to impact the field positively, showcasing her dedication to innovation and research.